|
|
|
|
LEADER |
03134nam a2200745 4500 |
001 |
ocn696008239 |
003 |
OCoLC |
005 |
20170124070911.1 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110110s2011 njua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d DG1
|d EBLCP
|d YDXCP
|d DG1
|d OCLCQ
|d E7B
|d OCLCQ
|d CDX
|d IDEBK
|d OCLCF
|d OCLCQ
|d NLGGC
|d NLE
|d DEBBG
|d OCLCQ
|d COO
|d OCLCQ
|d D6H
|d GrThAP
|
019 |
|
|
|a 689995807
|a 860514879
|
020 |
|
|
|a 9780470909768
|q (electronic bk.)
|
020 |
|
|
|a 0470909765
|q (electronic bk.)
|
020 |
|
|
|a 9780470909775
|q (electronic bk.)
|
020 |
|
|
|a 0470909773
|q (electronic bk.)
|
020 |
|
|
|z 9780470577554
|
020 |
|
|
|z 047057755X
|
024 |
7 |
|
|a 10.1002/9780470909775
|2 doi
|
029 |
1 |
|
|a AU@
|b 000046644178
|
029 |
1 |
|
|a DEBBG
|b BV041909796
|
029 |
1 |
|
|a NZ1
|b 14693606
|
029 |
1 |
|
|a NZ1
|b 15915759
|
029 |
1 |
|
|a DEBBG
|b BV043392686
|
035 |
|
|
|a (OCoLC)696008239
|z (OCoLC)689995807
|z (OCoLC)860514879
|
037 |
|
|
|a 10.1002/9780470909775
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
050 |
|
4 |
|a RS403
|b .H37 2011eb
|
060 |
|
4 |
|a QV 744
|b H311p 2011
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.19
|2 22
|
049 |
|
|
|a MAIN
|
100 |
1 |
|
|a Harrington, Peter J.
|
245 |
1 |
0 |
|a Pharmaceutical process chemistry for synthesis :
|b rethinking the routes to scale-up /
|c Peter J. Harrington.
|
264 |
|
1 |
|a Hoboken, N.J. :
|b Wiley,
|c [2011]
|
264 |
|
4 |
|c ©2011
|
300 |
|
|
|a 1 online resource (v, 369 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Actos (pioglitazone hydrochloride) -- Lexapro (escitalopram oxalate) -- Effexor XR (venlafaxine hydrochloride) -- Seroquel (quetiapine hemifumarate) -- Singulair (montelukast sodium) -- Prevacid (lansoprazole) -- Advair diskus (salmeterol xinafoate) -- Lipitor (atorvastatin calcium).
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Chemical processes.
|
650 |
|
4 |
|a Medicine.
|
650 |
|
4 |
|a Pharmacy.
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Chemical processes.
|2 fast
|0 (OCoLC)fst00853156
|
650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|x methods.
|
650 |
|
2 |
|a Chemistry Techniques, Analytical.
|
650 |
|
2 |
|a Drug Discovery.
|
650 |
|
2 |
|a Pharmaceutical Preparations
|x chemical synthesis.
|
650 |
|
2 |
|a Technology, Pharmaceutical
|x methods.
|
655 |
|
4 |
|a Electronic books.
|
776 |
0 |
8 |
|i Print version:
|a Harrington, Peter J.
|t Pharmaceutical process chemistry for synthesis.
|d Hoboken, N.J. : Wiley, ©2011
|z 9780470577554
|w (DLC) 2010019510
|w (OCoLC)614271483
|
856 |
4 |
0 |
|u https://doi.org/10.1002/9780470909775
|z Full Text via HEAL-Link
|
994 |
|
|
|a 92
|b DG1
|